Ditchcarbon
  • Contact
  1. Organizations
  2. Arvinas, Inc.
Public Profile
Pharmaceutical Preparation Manufacturing
US
updated 25 days ago

Arvinas, Inc.

Company website

Arvinas, Inc., a pioneering biotechnology company headquartered in the United States, is at the forefront of developing innovative therapies through its proprietary PROTAC® (Proteolysis Targeting Chimera) technology. Founded in 2013, Arvinas has made significant strides in the biopharmaceutical industry, focusing on targeted protein degradation to address unmet medical needs in oncology and other serious diseases. With a strong operational presence in key regions across the US, Arvinas is dedicated to advancing its pipeline of drug candidates, which uniquely harness the body's natural degradation mechanisms to eliminate disease-causing proteins. The company has garnered attention for its strategic partnerships and collaborations, positioning itself as a leader in the field of targeted therapies. Arvinas continues to push the boundaries of science, aiming to transform the treatment landscape for patients worldwide.

DitchCarbon Score

How does Arvinas, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

25

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

32

Industry Benchmark

Arvinas, Inc.'s score of 25 is lower than 55% of the industry. This can give you a sense of how well the company is doing compared to its peers.

45%

Let us know if this data was useful to you

Arvinas, Inc.'s reported carbon emissions

Arvinas, Inc., headquartered in the US, currently does not have available carbon emissions data for the most recent year, nor does it report specific reduction targets or initiatives. The company has not disclosed any commitments to the Science Based Targets initiative (SBTi) or other climate pledges. As such, there are no specific figures regarding their carbon footprint, including Scope 1, 2, or 3 emissions. Without concrete emissions data or reduction targets, it is unclear how Arvinas, Inc. is addressing climate change within its operations. The absence of reported initiatives suggests a potential area for development in their sustainability strategy.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Arvinas, Inc.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Arvinas, Inc. is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Arvinas, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Novartis

CH
•
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Zymeworks Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 29 days ago

Gilead Sciences

US
•
Pharmaceutical Preparation Manufacturing
Updated 4 days ago

Johnson And Johnson

US
•
Pharmaceutical Preparation Manufacturing
Updated about 4 hours ago

Eli Lilly and Company

GB
•
Pharmaceutical Preparation Manufacturing
Updated about 20 hours ago

Vertex Pharmaceuticals

US
•
Pharmaceutical Preparation Manufacturing
Updated 11 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251009.1
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy